Seeking Alpha

BioCryst Pharmaceuticals (BCRX): Q4 EPS of $0.35 beats by $0.26. Revenue of $55M (+60.5%) vs....

BioCryst Pharmaceuticals (BCRX): Q4 EPS of $0.35 beats by $0.26. Revenue of $55M (+60.5%) vs. $23.6M. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|